# Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2

> **NCT05427461** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut Claudius Regaud** · enrollment: 20 (estimated)

## Conditions studied

- Leiomyosarcoma

## Interventions

- **OTHER:** Blood samples will be collected at different times.

## Key facts

- **NCT ID:** NCT05427461
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-13
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427461, "Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05427461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*